Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Pharmaceuticals: Global Industry Guide

Published by: Datamonitor

Published: Feb. 28, 2008 - 243 Pages


Table of Contents


CHAPTER 1 Introduction
1.1 What is this report about?
1.2 Who is the target reader?
1.3 How to use this report
1.4 Definitions
CHAPTER 2 Global Pharmaceuticals
2.1 Market Overview
2.2 Market Value
2.3 Market Segmentation I
2.4 Market Segmentation II
2.5 Market Share
2.6 Five Forces Analysis
2.7 Market Forecasts
CHAPTER 3 Pharmaceuticals in Canada
3.1 Market Overview
3.2 Market Value
3.3 Market Segmentation I
3.4 Market Segmentation II
3.5 Market Share
3.6 Five Forces Analysis
3.7 Market Forecasts
3.8 Macroeconomic Indicators
CHAPTER 4 Pharmaceuticals in the United States
4.1 Market Overview
4.2 Market Value
4.3 Market Segmentation I
4.4 Market Segmentation II
4.5 Market Share
4.6 Five Forces Analysis
4.7 Market Forecasts
4.8 Macroeconomic Indicators
CHAPTER 5 Pharmaceuticals in China
5.1 Market Overview
5.2 Market Value
5.3 Market Segmentation I
5.4 Market Segmentation II
5.5 Market Share
5.6 Five Forces Analysis
5.7 Market Forecasts
5.8 Macroeconomic Indicators
CHAPTER 6 Pharmaceuticals in Japan
6.1 Market Overview
6.2 Market Value
6.3 Market Segmentation I
6.4 Market Segmentation II
6.5 Market Share
6.6 Five Forces Analysis
6.7 Market Forecasts
6.8 Macroeconomic Indicators
CHAPTER 7 Pharmaceuticals in Belgium
7.1 Market Overview
7.2 Market Value
7.3 Market Segmentation I
7.4 Market Segmentation II
7.5 Market Share
7.6 Five Forces Analysis
7.7 Market Forecasts
7.8 Macroeconomic Indicators
CHAPTER 8 Pharmaceuticals in France
8.1 Market Overview
8.2 Market Value
8.3 Market Segmentation I
8.4 Market Segmentation II
8.5 Market Share
8.6 Five Forces Analysis
8.7 Market Forecasts
8.8 Macroeconomic Indicators
CHAPTER 9 Pharmaceuticals in Germany
9.1 Market Overview
9.2 Market Value
9.3 Market Segmentation I
9.4 Market Segmentation II
9.5 Market Share
9.6 Five Forces Analysis
9.7 Market Forecasts
9.8 Macroeconomic Indicators
CHAPTER 10 Pharmaceuticals in Italy
10.1 Market Overview
10.2 Market Value
10.3 Market Segmentation I
10.4 Market Segmentation II
10.5 Market Share
10.6 Five Forces Analysis
10.7 Market Forecasts
10.8 Macroeconomic Indicators
CHAPTER 11 Pharmaceuticals in the Netherlands
11.1 Market Overview
11.2 Market Value
11.3 Market Segmentation I
11.4 Market Segmentation II
11.5 Market Share
11.6 Five Forces Analysis
11.7 Market Forecasts
11.8 Macroeconomic Indicators
CHAPTER 12 Pharmaceuticals in Spain
12.1 Market Overview
12.2 Market Value
12.3 Market Segmentation I
12.4 Market Segmentation II
12.5 Market Share
12.6 Five Forces Analysis
12.7 Market Forecasts
12.8 Macroeconomic Indicators
CHAPTER 13 Pharmaceuticals in the United Kingdom
13.1 Market Overview
13.2 Market Value
13.3 Market Segmentation I
13.4 Market Segmentation II
13.5 Market Share
13.6 Five Forces Analysis
13.7 Market Forecasts
13.8 Macroeconomic Indicators
CHAPTER 14 Pharmaceuticals in Asia-Pacific
14.1 Market Overview
14.2 Market Value
14.3 Market Segmentation I
14.4 Market Segmentation II
14.5 Market Share
14.6 Five Forces Analysis
14.7 Market Forecasts
CHAPTER 15 Pharmaceuticals in Europe
15.1 Market Overview
15.2 Market Value
15.3 Market Segmentation I
15.4 Market Segmentation II
15.5 Market Share
15.6 Five Forces Analysis
15.7 Market Forecasts
15.8 Macroeconomic Indicators
CHAPTER 16 COMPANY PROFILES
16.1 Leading Companies
CHAPTER 17 Appendix
17.1 Data Research Methodology
17.2 Report writing team
List of Tables
Table 1: Global Pharmaceuticals Market Value: $ million, 2003-2007
Table 2: Global Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 3: Global Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 4: Global Pharmaceuticals Market Share: % Share, by Value, 2007
Table 5: Global Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 6: Canada Pharmaceuticals Market Value: $ million, 2003-2007
Table 7: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 8: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 9: Canada Pharmaceuticals Market Share: % Share, by Value, 2007
Table 10: Canada Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 11: Canada Size of Population (million) , 2003-2007
Table 12: Canada GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 13: Canada Inflation, 2003-2007
Table 14: Canada Exchange Rate, 2003-2007
Table 15: United States Pharmaceuticals Market Value: $ million, 2003-2007
Table 16: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 17: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 18: United States Pharmaceuticals Market Share: % Share, by Value, 2007
Table 19: United States Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 20: United States Size of Population (million) , 2003-2007
Table 21: United States GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 22: United States Inflation, 2003-2007
Table 23: China Pharmaceuticals Market Value: $ million, 2003-2007
Table 24: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 25: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 26: China Pharmaceuticals Market Share: % Share, by Value, 2007
Table 27: China Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 28: China Size of Population (million) , 2003-2007
Table 29: China GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 30: China Inflation, 2003-2007
Table 31: China Exchange Rate, 2003-2007
Table 32: Japan Pharmaceuticals Market Value: $ million, 2003-2007
Table 33: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 34: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 35: Japan Pharmaceuticals Market Share: % Share, by Value, 2007
Table 36: Japan Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 37: Japan Size of Population (million) , 2003-2007
Table 38: Japan GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 39: Japan Exchange Rate, 2003-2007
Table 40: Belgium Pharmaceuticals Market Value: $ million, 2003-2007
Table 41: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 42: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 43: Belgium Pharmaceuticals Market Share: % Share, by Value, 2007
Table 44: Belgium Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 45: Belgium Size of Population (million) , 2003-2007
Table 46: Belgium GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 47: Belgium Inflation, 2003-2007
Table 48: Belgium Exchange Rate, 2003-2007
Table 49: France Pharmaceuticals Market Value: $ million, 2003-2007
Table 50: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 51: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 52: France Pharmaceuticals Market Share: % Share, by Value, 2007
Table 53: France Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 54: France Size of Population (million) , 2003-2007
Table 55: France GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 56: France Inflation, 2003-2007
Table 57: France Exchange Rate, 2003-2007
Table 58: Germany Pharmaceuticals Market Value: $ million, 2003-2007
Table 59: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 60: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 61: Germany Pharmaceuticals Market Share: % Share, by Value, 2007
Table 62: Germany Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 63: Germany Size of Population (million) , 2003-2007
Table 64: Germany GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 65: Germany Inflation, 2003-2007
Table 66: Germany Exchange Rate, 2003-2007
Table 67: Italy Pharmaceuticals Market Value: $ million, 2003-2007
Table 68: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 69: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 70: Italy Pharmaceuticals Market Share: % Share, by Value, 2007
Table 71: Italy Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 72: Italy Size of Population (million) , 2003-2007
Table 73: Italy GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 74: Italy Inflation, 2003-2007
Table 75: Italy Exchange Rate, 2003
Table 76: Netherlands Pharmaceuticals Market Value: $ million, 2003-2007
Table 77: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 78: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 79: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2007
Table 80: Netherlands Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 81: Netherlands Size of Population (million) , 2003-2007
Table 82: Netherlands GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 83: Netherlands Inflation, 2003-2007
Table 84: Netherlands Exchange Rate, 2003-2007
Table 85: Spain Pharmaceuticals Market Value: $ million, 2003-2007
Table 86: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 87: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 88: Spain Pharmaceuticals Market Share: % Share, by Value, 2007
Table 89: Spain Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 90: Spain Size of Population (million) , 2003-2007
Table 91: Spain GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 92: Spain Inflation, 2003-2007
Table 93: Spain Exchange Rate, 2003-2007
Table 94: United Kingdom Pharmaceuticals Market Value: $ million, 2003-2007
Table 95: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 96: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 97: United Kingdom Pharmaceuticals Market Share: % Share, by Value, 2007
Table 98: United Kingdom Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 99: United Kingdom Size of Population (million) , 2003-2007
Table 100: United Kingdom GDP (Constant 2000 Prices, $ billion), 2003-2007
Table 101: United Kingdom Inflation, 2003-2007
Table 102: United Kingdom Exchange Rate, 2003-2007
Table 103: Asia-Pacific Pharmaceuticals Market Value: $ million, 2003-2007
Table 104: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 105: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 106: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2007
Table 107: Asia-Pacific Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 108: Europe Pharmaceuticals Market Value: $ million, 2003-2007
Table 109: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Table 110: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Table 111: Europe Pharmaceuticals Market Share: % Share, by Value, 2007
Table 112: Europe Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Table 113: Europe Exchange Rate, 2003-2007
Table 114: Key Facts: Pfizer Inc
Table 115: Key Financials: Pfizer Inc
Table 116: Key Facts: GlaxoSmithKline Plc
Table 117: Key Financials: GlaxoSmithKline Plc
Table 118: Key Facts: Johnson & Johnson
Table 119: Key Financials: Johnson & Johnson
Table 120: Key Facts: Merck & Co., Inc.
Table 121: Key Financials: Merck & Co., Inc.
List of Figures
Figure 1: Global Pharmaceuticals Market Value: $ million, 2003-2007
Figure 2: Global Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Figure 3: Global Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Figure 4: Global Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 5: Forces Driving Competition in the Global Pharmaceuticals Market, 2007
Figure 6: Drivers of Buyer Power in the Global Pharmaceuticals Market, 2007
Figure 7: Drivers of Supplier Power in the Global Pharmaceuticals Market, 2007
Figure 8: Factors Influencing the Likelihood of New Entrants in the Global Pharmaceuticals Market, 2007
Figure 9: Factors Influencing the Threat of Substitutes in the Global Pharmaceuticals Market, 2007
Figure 10: Drivers of Degree of Rivalry in the Global Pharmaceuticals Market, 2007
Figure 11: Global Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Figure 12: Canada Pharmaceuticals Market Value: $ million, 2003-2007
Figure 13: Canada Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Figure 14: Canada Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Figure 15: Canada Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 16: Forces Driving Competition in the Pharmaceuticals Market in Canada, 2007
Figure 17: Drivers of Buyer Power in the Pharmaceuticals Market in Canada, 2007
Figure 18: Drivers of Supplier Power in the Pharmaceuticals Market in Canada, 2007
Figure 19: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Canada, 2007
Figure 20: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Canada, 2007
Figure 21: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Canada, 2007
Figure 22: Canada Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Figure 23: United States Pharmaceuticals Market Value: $ million, 2003-2007
Figure 24: United States Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Figure 25: United States Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Figure 26: United States Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 27: Forces Driving Competition in the Pharmaceuticals Market in the US, 2007
Figure 28: Drivers of Buyer Power in the Pharmaceuticals Market in the US, 2007
Figure 29: Drivers of Supplier Power in the Pharmaceuticals Market in the US, 2007
Figure 30: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the US, 2007
Figure 31: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the US, 2007
Figure 32: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the US, 2007
Figure 33: United States Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Figure 34: China Pharmaceuticals Market Value: $ million, 2003-2007
Figure 35: China Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Figure 36: China Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Figure 37: China Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 38: Forces Driving Competition in the Pharmaceuticals Market in China, 2007
Figure 39: Drivers of Buyer Power in the Pharmaceuticals Market in China, 2007
Figure 40: Drivers of Supplier Power in the Pharmaceuticals Market in China, 2007
Figure 41: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in China, 2007
Figure 42: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in China, 2007
Figure 43: Drivers of Degree of Rivalry in the Pharmaceuticals Market in China, 2007
Figure 44: hina Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Figure 45: Japan Pharmaceuticals Market Value: $ million, 2003-2007
Figure 46: Japan Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Figure 47: Japan Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Figure 48: Japan Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 49: Forces Driving Competition in the Pharmaceuticals Market in Japan, 2007
Figure 50: Drivers of Buyer Power in the Pharmaceuticals Market in Japan, 2007
Figure 51: Drivers of Supplier Power in the Pharmaceuticals Market in Japan, 2007
Figure 52: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Japan, 2007
Figure 53: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Japan, 2007
Figure 54: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Japan, 2007
Figure 55: Japan Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Figure 56: Belgium Pharmaceuticals Market Value: $ million, 2003-2007
Figure 57: Belgium Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Figure 58: Belgium Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Figure 59: Belgium Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 60: Forces Driving Competition in the Pharmaceuticals Market in Belgium, 2007
Figure 61: Drivers of Buyer Power in the Pharmaceuticals Market in Belgium, 2007
Figure 62: Drivers of Supplier Power in the Pharmaceuticals Market in Belgium, 2007
Figure 63: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Belgium, 2007
Figure 64: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Belgium, 2007
Figure 65: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Belgium, 2007
Figure 66: Belgium Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Figure 67: France Pharmaceuticals Market Value: $ million, 2003-2007
Figure 68: France Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Figure 69: France Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Figure 70: France Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 71: Forces Driving Competition in the Pharmaceuticals Market in France, 2007
Figure 72: Drivers of Buyer Power in the Pharmaceuticals Market in France, 2007
Figure 73: Drivers of Supplier Power in the Pharmaceuticals Market in France, 2007
Figure 74: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in France, 2007
Figure 75: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in France, 2007
Figure 76: Drivers of Degree of Rivalry in the Pharmaceuticals Market in France, 2007
Figure 77: France Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Figure 78: Germany Pharmaceuticals Market Value: $ million, 2003-2007
Figure 79: Germany Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Figure 80: Germany Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Figure 81: Germany Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 82: Forces Driving Competition in the Pharmaceuticals Market in Germany, 2007
Figure 83: Drivers of Buyer Power in the Pharmaceuticals Market in Germany, 2007
Figure 84: Drivers of Supplier Power in the Pharmaceuticals Market in Germany, 2007
Figure 85: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Germany, 2007
Figure 86: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Germany, 2007
Figure 87: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Germany, 2007
Figure 88: Germany Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Figure 89: Italy Pharmaceuticals Market Value: $ million, 2003-2007
Figure 90: Italy Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Figure 91: Italy Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Figure 92: Italy Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 93: Forces Driving Competition in the Pharmaceuticals Market in Italy, 2007
Figure 94: Drivers of Buyer Power in the Pharmaceuticals Market in Italy, 2007
Figure 95: Drivers of Supplier Power in the Pharmaceuticals Market in Italy, 2007
Figure 96: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Italy, 2007
Figure 97: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Italy, 2007
Figure 98: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Italy, 2007
Figure 99: Italy Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Figure 100: Netherlands Pharmaceuticals Market Value: $ million, 2003-2007
Figure 101: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Figure 102: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Figure 103: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 104: Forces Driving Competition in the Pharmaceuticals Market in the Netherlands, 2007
Figure 105: Drivers of Buyer Power in the Pharmaceuticals Market in the Netherlands, 2007
Figure 106: Drivers of Supplier Power in the Pharmaceuticals Market in the Netherlands, 2007
Figure 107: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the Netherlands, 2007
Figure 108: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the Netherlands, 2007
Figure 109: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the Netherlands, 2007
Figure 110: Netherlands Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Figure 111: Spain Pharmaceuticals Market Value: $ million, 2003-2007
Figure 112: Spain Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Figure 113: Spain Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Figure 114: Spain Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 115: Forces Driving Competition in the Pharmaceuticals Market in Spain, 2007
Figure 116: Drivers of Buyer Power in the Pharmaceuticals Market in Spain, 2007
Figure 117: Drivers of Supplier Power in the Pharmaceuticals Market in Spain, 2007
Figure 118: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Spain, 2007
Figure 119: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Spain, 2007
Figure 120: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Spain, 2007
Figure 121: Spain Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Figure 122: United Kingdom Pharmaceuticals Market Value: $ million, 2003-2007
Figure 123: United Kingdom Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Figure 124: United Kingdom Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Figure 125: United Kingdom Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 126: Forces Driving Competition in the Pharmaceuticals Market in the United Kingdom, 2007
Figure 127: Drivers of Buyer Power in the Pharmaceuticals Market in the United Kingdom, 2007
Figure 128: Drivers of Supplier Power in the Pharmaceuticals Market in the United Kingdom, 2007
Figure 129: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the United Kingdom, 2007
Figure 130: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the United Kingdom, 2007
Figure 131: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the United Kingdom, 2007
Figure 132: United Kingdom Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Figure 133: Asia-Pacific Pharmaceuticals Market Value: $ million, 2003-2007
Figure 134: Asia-Pacific Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Figure 135: Asia-Pacific Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Figure 136: Asia-Pacific Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 137: Forces Driving Competition in the Pharmaceuticals Market in Asia-Pacific, 2007
Figure 138: Drivers of Buyer Power in the Pharmaceuticals Market in Asia-Pacific, 2007
Figure 139: Drivers of Supplier Power in the Pharmaceuticals Market in Asia-Pacific, 2007
Figure 140: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Asia-Pacific, 2007
Figure 141: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Asia-Pacific, 2007
Figure 142: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Asia-Pacific, 2007
Figure 143: Asia-Pacific Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Figure 144: Europe Pharmaceuticals Market Value: $ million, 2003-2007
Figure 145: Europe Pharmaceuticals Market Segmentation I: % Share, by Value, 2007
Figure 146: Europe Pharmaceuticals Market Segmentation II: % Share, by Value, 2007
Figure 147: Europe Pharmaceuticals Market Share: % Share, by Value, 2007
Figure 148: Forces Driving Competition in the Pharmaceuticals Market in Europe, 2007
Figure 149: Drivers of Buyer Power in the Pharmaceuticals Market in Europe, 2007
Figure 150: Drivers of Supplier Power in the Pharmaceuticals Market in Europe, 2007
Figure 151: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in Europe, 2007
Figure 152: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in Europe, 2007
Figure 153: Drivers of Degree of Rivalry in the Pharmaceuticals Market in Europe, 2007
Figure 154: Europe Pharmaceuticals Market Value Forecast: $ million, 2007-2012
Figure 155: Revenues & Profitability: Pfizer Inc
Figure 156: Revenues & Profitability: GlaxoSmithKline Plc
Figure 157: Revenues & Profitability: Johnson & Johnson
Figure 158: Revenues & Profitability: Merck & Co., Inc.


Abstract

Datamonitor's Pharmaceuticals: Global Industry Guide is an essential resource for top-level data and analysis covering the pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis on a global, regional and country basis.

Scope of the Report
  • Contains an executive summary and data on value, volume and segmentation
  • Provides textual analysis of the industry's prospects, competitive landscape and profiles of the leading companies
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Covers the Global, European and Asia-Pacific markets as well as individual chapters on 5 major markets (France, Germany, Japan, the UK and the US).
  • Includes a five-year forecast of the industry
Highlights

The global pharmaceuticals market grew by 5.5% in 2007 to reach a value of $577.2 billion.

In 2012, the market is forecast to have a value of $737.9 billion, an increase of 27.8% since 2007.

Sales of cardiovascular therapies account for 19.5% of the market by value.

The Americas is the largest pharmaceuticals market, accounting for 55% of the global market's value.

Pfizer is the leading company in the market, holding an 8.1% market share by value.

Why you should buy this report
  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research
Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2006 annual average exchange rates.

For the purpose of this report the Americas comprise Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2008